Mednet Logo
Community

Is Rad51D heterozygous mutation a contraindication to postmastectomy radiation?

1 Answer
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on

BRCA1/2, PALPB2, CHEK2, and RAD50/51 mutations should not affect radiation therapy https://www.redjournal.org/article/S0360-3016(19)33530-8/fulltext

Join for free or sign in to see the full answer